Reducing Alcohol Consumption in Alcohol Dependent Individuals: A Pilot Feasibility Study
Summary
A trial was conducted to check the potential of transdermal alcohol sensors (TASs) in reducing alcohol consumption in individuals undergoing treatment for alcohol use disorder (AUD). The study aimed to assess the feasibility of using TASs and contingency management (CM) for alcohol monitoring and promoting abstinence or low-level alcohol consumption.
Methods
30 participants were recruited and divided into two groups: control and CM. Both groups wore the TAS (BACtrack Skyn) for 2 weeks while continuing their regular treatment. The CM group received small financial rewards for low or no alcohol consumption, as measured by the TAS. The researcher monitored participants’ alcohol concentration and allocated incentives according to a set schedule.
Results
Data analysis is ongoing and is expected to be completed by June 2024. A total of 32 participants were enrolled.
Conclusions
The study is the first to explore the use of TAS in specialized alcohol services with diagnosed AUD individuals. The findings will help identify the potential of TAS to improve treatment outcomes in clinical alcohol treatment.
